1,202
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Non-controlled, open-label trial to assess clinical and immunological parameters in atopic dogs feeding monoprotein grain free diet versus a standard grain diet

, , , , , & show all
Pages 1-7 | Received 14 Feb 2023, Accepted 27 Jul 2023, Published online: 11 Aug 2023

References

  • Bensignor E, Morgan DM, Nuttal T. 2008. Efficacy of an essential fatty acid-enriched diet in managing canine atopic dermatitis: a randomized, single-blinded, cross-over study. Vet Dermatol. 19(3):156–162. doi: 10.1111/j.1365-3164.2008.00670.x.
  • Berker M, Frank LJ, Geßner AL, Grassl N, Holtermann AV, Höppner S, Kraef C, Leclaire MD, Maier P, Messerer DAC, et al. 2017. Allergies-A T cells perspective in the era beyond Th1/Th2 paradigm. Clinical Immunol. 174:73–83. doi: 10.1016/j.clim.2016.11.001.
  • De Caro Martins G, da Costa-Val AP, Coura FM, Diamantino GML, Nogueira MM, de Oliveira Melo-Junior OA, Giunchetti RC, da Silveira-Lemos D, Melo MM. 2022. Immunomodulatory effect of long-term oclacitinb maleate therapy in dogs with atopic dermatitis. Vet Dermatol. 33(2):142–e40. doi: 10.1111/vde.13037.
  • de Santiago MS, Arribas JLG, Llamas YM, Becvarova I, Meyer H. 2021. Randomized, double-blind, placebo-controlled clinical trial measuring the effect of a dietetic food on dermatologic scoring and pruritus in dogs with atopic dermatitis. BMC Vet Res. 17(1):354. doi: 10.1186/s12917-021-03063-w.
  • Di Cerbo A, Morales-Medina JC, Palmieri B, Pezzuto F, Cocco R, Flores G, Iannitti T. 2017. Functional foods in pet nutrition: focus on dogs and cats. Res Vet Sci. 112:161–166. doi: 10.1016/j.rvsc.2017.03.020.
  • Favrot C, Steffan J, Seewald W, Picco F. 2010. A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis. Vet Dermatol. 21(1):23–31. doi: 10.1111/j.1365-3164.2009.00758.x.
  • Gonzales AJ, Bowman JW, Fici GJ, Zhang M, Mann DW, Mitton-Fry M. 2014. Oclacitinib (APOQUEL®) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy. J Vet Pharmacol Ther. 37(4):317–324. doi: 10.1111/jvp.12101.
  • Gow DJ, Jackson H, Forsythe P, Nuttall T, Gow AG, Mellanby RJ, Hume DA. 2020. Measurement of serum Interleukin 34 (IL-34) and correlation with severity and pruritus scores in client-owned dogs with atopic dermatitis. Vet Dermatol. 31(5):359–e94. doi: 10.1111/vde.12873.
  • Hauck V, Hügli P, Meli ML, Rostaher A, Fischer N, Hofmann-Lehmann R, Favrot C. 2016. Increased number of FoxP3-expressing CD4+CD25+ regulatory T cells in peripheral blood from dogs with atopic dermatitis and its correlation with disease severity. Vet Dermatol. 27(1):26–e9. doi: 10.1111/vde.12279.
  • Herrmann I, Mamo LB, Holmes J, Mohammed JP, Murphy KM, Bizikova P. 2023. Long-term effects of ciclosporin and oclacitinib on mediators of tolerance, regulatory T-cells, IL-10 and TGF-β, in dogs with atopic dermatitis. Vet Dermatol. 34(2):107–114. doi: 10.1111/vde.13140.
  • Jasiecka-Mikołajczyk A, Jaroszewski JJ, Maślanka T. 2018. Oclacitinib depletes canine CD4+ and CD8+ T cells in vitro. Res Vet Sci. 121:124–129. doi: 10.1016/j.rvsc.2018.10.014.
  • Keppel KE, Campbell KL, Zuckermann FA, Greeley EA, Schaeffer DJ, Husmann RJ. 2008. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy. Vet Immunol Immunopathol. 123(3–4):337–344. doi: 10.1016/j.vetimm.2008.02.008.
  • Koury J, Ramirez A, Xie C, Harb J, Dong C, Maki C, Ramos T, Izadyar F, Clark D, Drechsler Y, et al. 2019. Phosphodiesterase 4D, miR-203 and selected cytokines in the peripheral blood are associated with canine atopic dermatitis. PLoS One. 14(6):e0218670. doi: 10.1371/journal.pone.0218670.
  • Lee D-J, Chung T-H, Park C. 2020. Quantitative analysis of CD4+CD25+FoxP3+ regulatory T-cells in canine atopic dermatitis in Korea. Vet Med. 65(6):250–257. doi: 10.17221/20/2019-VETMED.
  • Majewska A, Gajewska M, Dembele K, Maciejewski H, Prostek A, Jank M. 2016. Lymphocytic, cytokine and transcriptomic profiles in peripheral blood dogs with atopic dermatitis. BMC Vet Res. 12(1):174. doi: 10.1186/s12917-016-0805-6.
  • Marsella R. 2021. Advances in our understanding of canine atopic dermatitis. Vet Dermatol. 32(6):547–e151. doi: 10.1111/vde.12965.
  • Martins GDC, de Oliveira Melo Júnior OA, Botoni LS, Nogueira MM, da Costa Val AP, Blanco BS, Dutra WO, Giunchetti RC, Melo MM, da Silveira Lemos D, et al. 2018. Clinical-pathological and immunological biomarkers in dogs with atopic dermatitis. Vet Immunol Immunopathol. 205:58–64. doi: 10.1016/j.vetimm.2018.10.009.
  • Mazrier H, Vogelnest LJ, Taylor RM, Williamson P. 2022. Altered plasma cytokines in dogs with atopic dermatitis. Vet Dermatol. 33(2):131–e38. doi: 10.1111/vde.13044.
  • Michels GM, Walsh KF, Kryda KA, Mahabir SP, Walters RR, Hoevers JD, Martinon OM. 2016. A blinded, ramdomized, placebo-cpontrolled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis. Vet Dermatol. 27(6):505–e136. doi: 10.1111/vde.12364.
  • Olivry T, Saridomichelakis M, Nuttall T, Bensignor E, Griffin CE, Hill PB. 2014. Validation of the Canine Atopic Dermatitis Extend and Severity Index (CADESI-4), a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs. Vet Dermatol. 25(2):77–e25. doi: 10.1111/vde.12107.
  • Pucheu-Haston CM, Bizikova P, Marsella R, Santoro D, Nuttall T, Eisenschenk MNC. 2015a. Review: lymphocytes, cytokines, chemokines and the T-helper 1-T-helper 2 balance in canine atopic dermatitis. Vet Dermatol. 26(2):124–e32. doi: 10.1111/vde.12205.
  • Pucheu-Haston CM, Santoro D, Bizikova P, Eisenschenk MNC, Marsella R, Nuttall T. 2015b. Review: innate immunity, lipid metabolism and nutrition in canine atopic dermatitis. Vet Dermatol. 26(2):104–e28. doi: 10.1111/vde.12199.
  • Rostaher A, Fischer NM, Urwyler A, Favrot C. 2018. Circulating CD4(+)CD25(+)Foxp3(+) T regulatory cell levels in an experimental model of canine atopic dermatitis. Vet Dermatol. 29(6):511–e171. doi: 10.1111/vde.12693.
  • Rybnícek J, Lau-Gillard PJ, Harvey R, Hill PB. 2009. Further validation of a pruritus severity scale for use in dogs. Vet Dermatol. 20(2):115–122. doi: 10.1111/j.1365-3164.2008.00728.x.
  • Stoeckel K, Nielsen LH, Fuhrmann H, Bachmann L. 2011. Fatty acid patterns of dog erythrocyte membranes after feeding of a fish-oil based DHA-rich supplement with a base diet low in n-3 fatty acids versus a diet containing added n-3 fatty acids. Acta Vet Scan. 53:57.
  • Szczepanik MP, Golynski M, Wilkolek P, Kalisz G. 2022. Evaluation of a hydrolysed salmon and pea hypoallergenic diet application in dog’s and cat’s with cutaneous adverse food reaction. Pol J Vet Sci. 25:1–7.
  • Verde MT, Villanueva-Saz S, Loste A, Marteles D, Pereboom D, Conde T, Fernández A. 2022. Comparison of circulating CD4+, CD8+ lymphocytes and cytokine profiles between dogs with atopic dermatitis and healthy dogs. Res Vet Sci. 145:13–20. doi: 10.1016/j.rvsc.2022.01.018.
  • Watson A, Rostaher A, Fischer NM, Favrot C. 2022. A novel therapeutic diet can significantly reduce the medication score and pruritus of dogs with atopic dermatitis during a nine month controlled study. Vet Dermatol. 33(1):55–e18. doi: 10.1111/vde.13020.
  • Witzel-Rollins A, Murphy M, Becvarova I, Werre SR, Cadiergues M-C, Meyer H. 2019. Non-controlled, open-labeled clinical trial to assess the effectiveness of a dietetic food on pruritus and dermatologic scoring in atopic dogs. BMC Vet Res. 15(1):220. doi: 10.1186/s12917-019-1929-2.